2011 Cancer Report

2011 Cancer Report — Cancer Site Analysis of ovarian Cancer


Our Cancer Program

The Oncology Committee of Manatee Memorial Hospital is pleased to present this report of MMH Cancer Program activities during 2011. Except where expressly noted, the Cancer Registry data in this report is from 2010.

The Commission on Cancer (CoC) has approved the MMH cancer program as a Community Hospital Cancer Program (CHCP). To achieve approval status a facility must show that its patients have access to all major modalities of cancer treatment, either on site or by referral, and meet national standards for multidisciplinary interaction by the entire cancer care team. Besides cancer diagnostic, staging and treatment modalities, these standards require ongoing performance improvement, demonstration of adherence to quality measures, outcomes analyses, staff education, patient support services and community outreach activities.

In 2011 the MMH Cancer Program activities included the following highlights:

  • Began renovation to Oncology Unit
  • Installation of Microwave Tissue Processor-improve quality of tissue; decrease turn around time of results; use less reagents for processing
  • Expansion of Laboratory-reduce the number of test that are being sent to outside resulting in reduce turn around time of results; provide more lab services to community
  • Increased attendance of the LECOM medical students at the Cancer Conferences
  • Implement Forms on Demand-improve patient safety by eliminating putting patient labels on medical record forms and physician orders
  • “No One Dies Alone” program which clergy makes two visits per month
  • Implemented Residency Program, Residency program implemented in June 2011 in Family Practice and Internal Medicine
  • Quarterly “Open Patient Safety Forums” to improve patient safety through continuous dialect between all patient care providers  
  • Tobacco prevention & cessation awareness monthly sessions and also available on MMH website and in the hospital news updates
  • Breast Care Awareness activities in month of October
  • Public forums discussing topics such as: “Practical Strategies in Contemporary Healthcare”, presented by Tidewell Hospice/Keiser University, “Prevention of Medical Errors”, presented by Dr. A. Ferretti, “Advanced Treatments in Lung Cancer”, presented by Dr. R. Smith, MD, “Women’s Health: Treatment options & advances for Cervical Cancer”, presented by Dr. M. Koshy/Dr. S. South, and “Men’s Health: The latest on Prostate Cancer”, presented by Dr. S. Castellucci
  • Women Living with Cancer Support Group presented by Katie Powers, RN
  • Installed new sound system in physicians lounge for Cancer Conferences

The success of the above only exists through the extraordinary day to day cancer patient care activities. MMH feels that providing the best cancer care lies with each professional individual member providing quality care and support to our cancer patients.

MMH frequently collaborates with the American Cancer Society, the American Lung Association, the Manatee County Health Department and the Wellness Community to provide cancer support, cancer screenings and educational services to the local cancer patient population.

Summary of Cancer Registry Data for 2010

A total of 831 new cancer patients were treated at MMH during 2010. Of these, 613 (74%) were analytic (newly diagnosed) and 218 (26%) were non-analytic (diagnosed and completed first-course therapy elsewhere). Since January 1, 2004, cancer registries have been required by federal and state legislation to also collect and report benign brain tumors.

The demographic (sex, race, age) distributions of our analytical cancer patient populations is important for planning effective cancer services. This information can provide MMH insight in identifying what additional services such as treatment modalities and support services are needed in the community. In 2010, the sex distribution was 60% female cancer patients and 40% male cancer patients. The largest age group diagnosed with cancer were patients 70 years or older which represent 43% of our 2010 cancer cases.

Age at Diagnosis

Determining the stage or extent of cancer is critical to making effective treatment decisions. The staging system used for this report is the Collaborative Staging System (CSS) developed by the American Joint Committee on Cancer (AJCC), the Commission on Cancer (CoC), and the Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute with collaboration from multiple national and state cancer organizations. The CSS staging system uses an algorithm to derive from staging factors collected by cancer registries a stage that may combine clinical and pathologic tumor (T), lymph node (N) and metastatic (M) components. The overall AJCC stage distribution of MMH analytic cancer cases is as follows:

  • Stage 0 – 9%
  • Stage 1 – 24%
  • Stage 2 – 14%
  • Stage 3 – 15%
  • Stage 4 –  15 %
  • Stage Unknown – 13%     
  • Stage Not Applicable – 10%

Stage distributions for specific primary sites can be found on the MMH site distribution table:

2010 Primary Cancer Sites Distribution Table

The National comparison of the five most prevalent cancer sites seen at MMH during 2010 were breast (23%), lung (18%), colorectal (11%), uterus (5%) and bladder (6%), prostate (2%), see chart below.  Per the Cancer Facts & Figures 2010 published by the American Cancer Society, the five most prevalent cancer sites in the United States were breast, lung, prostate, colorectal, bladder respectively. Per the same source, the five most common cancers in Florida were the same sites listed as lung, breast, prostate, colorectal and bladder respectively.

5 Most Prevalent Sites

This Draft Has Sidebar Blocks
Sidebar Block 1
2011 Oncology

Manatee Memorial Hospital’s Cancer Program is approved by the Commission on Cancer of the American College of Surgeons

K. Telukuntla, MD
Medical Oncology

S. Tanev, MD
ACoS Cancer Liaison Physician for
Manatee Memorial Hospital

D. Grandrimo, MD
Palliative Care

T. J. Farrell, MD

A. S. Hassan, MD

Y. Nadiminti, MD
Medical Oncology

J. Pecoraro, MD

D. Fitch, MD
Radiation Oncology

C. Turalba, MD
Radiation Oncology

T. Nguyen, MD
Radiation Oncology

M. Koshy, MD
Radiation Oncology

G. Skarulis, MD

S. South, MD
Oncology Surgery

J. Wasserman, D.O.

Non-Physician Members:

B. Dearmon, CTR
Cancer Registrar

A. Dixon
Cancer Registrar

T. Buchanan, RN
P.I. & Risk Management

B. Chambliss
Marketing & Community Relations

M. Conner, RN
Case Manager

S. Drackett, PharmD

N. Dugas, RN
Outpatient Surgery

G. Fisher, DMin

R. Fletcher
Chief Operating Officer

J. Hawkins, RN
Oncology Unit

B. Heinz, RHIA
Health Information Management/ Cancer Registry

P. Jefferson, RN
Imaging Services

C. Malloy, RN
Chief Nursing Officer

D. Mann, RN
Women’s and Children’s and Medical Surgical Services

D. Sullivan
Chief Financial Officer

Sidebar Block 2
Sidebar Block 3
Sidebar Block 4
Manatee Memorial Hospital is owned and operated by a subsidiary of Universal Health Services, Inc. (UHS), a King of Prussia, PA-based company, that is one of the largest healthcare management companies in the nation.      

Manatee Memorial Hospital

206 Second Street East
Bradenton, FL 34208

© 2016 Manatee Memorial Hospital. All rights reserved.

Note:The information on this website is provided as general health guidelines and may not be applicable to your particular health condition. Your individual health status and any required medical treatments can only be properly addressed by a professional healthcare provider of your choice. Remember: There is no adequate substitution for a personal consultation with your physician. Neither Manatee Memorial Hospital, or any of their affiliates, nor any contributors shall have any liability for the content or any errors or omissions in the information provided by this website.      

The information, content and artwork provided by this Web site is intended for non-commercial use by the reader. The reader is permitted to make one copy of the information displayed for his/her own non-commercial use. The making of additional copies is prohibited.